Sequenom (SQNM) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts SQNM Hot Sheet
Price: $2.39 --0%
Financial Fact:
Genetic analysis product sales and services: 2.78M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Genetic analysis product sales and services: 2.78M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Sequenom (NASDAQ: SQNM) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $27.8 million.
Fourth quarter total accessions of 42,200, up from 41,000 in Q3 2015
Fourth quarter noninvasive prenatal test (NIPT) accessions of 37,300, up from 35,500 in Q3 2015
For earnings history and earnings-related data on Sequenom (SQNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
